MedPage Today on MSN
Investigational GLP-1-Based Drug Hits MASH Resolution Mark, Misses Fibrosis Target
WASHINGTON -- Treatment with the investigational GLP-1/glucagon dual receptor agonist pemvidutide led to resolution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback